Pei Z, Xin Z, Liu G, Li Y, Reilly E B, Lubbers N L, Huth J R, Link J T, von Geldern T W, Cox B F, Leitza S, Gao Y, Marsh K C, DeVries P, Okasinski G F
Department of Metabolic Disease Research, Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, Illinois 60064, USA.
J Med Chem. 2001 Aug 30;44(18):2913-20. doi: 10.1021/jm010059w.
The interaction of LFA-1 and ICAM-1 plays an important role in the cell adhesion process. On the basis of previously reported SAR and structural information on the binding of our p-arylthiocinnamide series to LFA-1, we have identified the cyclic amide (C-ring) as a site for modification. Improvement in potency and, more importantly, in the physical properties and pharmacokinetic profiles of the leading compounds resulted from this modification. One of the best compounds (11f) is also shown to reduce myocardial infarct size in rat.